Clinical value of plasma soluble Urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: A prospective study

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Siahanidou, Tania ^a   Margeli, Alexandra ^b   Tsirogianni, Chrysanthi ^a   Charoni, Stavroula ^a   Giannaki, Maria ^b   Vavourakis, Eustathios ^b   Charisiadou, Athina ^b   Papassotiriou, Ioannis ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; UROKINASE RECEPTOR; BIOLOGICAL MARKER; PLAUR PROTEIN, HUMAN;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; VIRUS INFECTION; BACTERIAL INFECTIONS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; PHYSIOLOGY; PROGNOSIS; SEPSIS; TIME; VIRUS DISEASES;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; ROC CURVE; SEPSIS; TIME FACTORS; VIRUS DISEASES;

EID: 84901815743     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/375702     Document Type: Article

References (27)

1. Mussap M., Noto A., Cibecchini F., Fanos V., The importance of biomarkers in neonatology. Seminars in Fetal & Neonatal Medicine 2013 18 1 56 64 10.1016/j.siny.2012.10.006
2. Ng P. C., Lam H. S., Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clinics in Perinatology 2010 37 3 599 610 2-s2.0-77956168341 10.1016/j.clp.2010.05.005
3. Thunø M., MacHo B., Eugen-Olsen J., SuPAR: the molecular crystal ball. Disease Markers 2009 27 3-4 157 172 2-s2.0-73349125115 10.3233/DMA-2009-0657
4. Tzanakaki G., Paparoupa M., Kyprianou M., Barbouni A., Eugen-Olsen J., Kourea-Kremastinou J., Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome. European Journal of Clinical Microbiology and Infectious Diseases 2012 31 6 1157 1162 2-s2.0-80053440550 10.1007/s10096-011-1423-7
5. Franco Palacios C. R., Lieske J. C., Wadei H. M., Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation 2013 96 394 399
6. Donadello K., Scolletta S., Covajes C., Vincent J.-L., SuPAR as a prognostic biomarker in sepsis. BMC Medicine 2012 10, article 2 2-s2.0-84855381301 10.1186/1741-7015-10-2
7. Kofoed K., Andersen O., Kronborg G., Tvede M., Petersen J., Eugen-Olsen J., Larsen K., Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Critical Care 2007 11, article R38 2-s2.0-34247328556 10.1186/cc5723 (Pubitemid 46629292)
8. Koch A., Voigt S., Kruschinski C., Sanson E., Dückers H., Horn A., Yagmur E., Zimmermann H., Trautwein C., Tacke F., Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care 2011 15, article R63 2-s2.0-79951557734 10.1186/cc10037
9. Backes Y., van der Sluijs K. F., Mackie D. P., Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Medicine 2012 38 9 1418 1428 10.1007/s00134-012-2613-1
10. Kingsmore S. F., Kennedy N., Halliday H. L., van Velkinburgh J. C., Zhong S., Gabriel V., Grant J., Beavis W. D., Tchernev V. T., Perlee L., Lejnine S., Grimwade B., Sorette M., Edgar J. D. M., Identification of diagnostic biomarkers for infection in premature neonates. Molecular and Cellular Proteomics 2008 7 10 1863 1875 2-s2.0-55049095251 10.1074/mcp.M800175-MCP200
11. Goldstein B., Giroir B., Randolph A., International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine 2005 6 1 2 8 2-s2.0-21644438082 10.1097/01.PCC.0000149131.72248.E6 (Pubitemid 40956461)
12. Perch M., Kofoed P. E., Fischer T. K., Có F., Rombo L., Aaby P., Eugen-Olsen J., Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunology 2004 26 5 207 211 2-s2.0-7444265832 10.1111/j.0141-9838.2004.00695.x (Pubitemid 39440864)
13. Wrotek A., Pawlik K., Jackowska T., Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children. Neurobiology of Respiration 2013 788 329 334 Advances in Experimental Medicine and Biology 10. 1007/978-94-007-6627-3-44
14. Wittenhagen P., Andersen J. B., Hansen A., Lindholm L., Rønne F., Theil J., Tvede M., Eugen-Olsen J., Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection. Biomarker Insights 2011 6 79 82 2-s2.0-80053601245 10.4137/BMI.S6876
15. Hoenigl M., Raggam R. B., Wagner J., Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clinical Biochemistry 2013 46 3 225 229 10.1016/j.clinbiochem.2012.11.004
16. Donadello K., Scolletta S., Taccone F. S., Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients. Journal of Critical Care 2014 29 1 144 149 10.1016/j.jcrc.2013.08.005
17. Suberviola B., Castellanos-Ortega A., Ruiz Ruiz A., Lopez-Hoyos M., Santibanez M., Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Medicine 2013 39 11 1945 1952 10.1007/s00134-013-3056-z
18. Uusitalo-Seppala R., Huttunen R., Tarkka M., Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study. Journal of Internal Medicine 2012 272 3 247 256 10.1111/j.1365-2796.2012.02569.x
19. Giamarellos-Bourboulis E. J., Norrby-Teglund A., Mylona V., Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Critical Care 2012 16 4, article R149
20. Dajak M., Ignjatović S., Majkić-Singh N., Laušević Ž., Bukumirović V., Prognostic value of phospholipase A2 group II, C-reactive protein and simplified acute physiological score II in intensive care patients. Clinical Laboratory 2006 52 7-8 387 392 2-s2.0-33748367425 (Pubitemid 44336221)
21. Adly A. A., Ismail E. A., Andrawes N. G., El-Saadany M. A., Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine 2013 65 2 184 191 10.1016/j.cyto.2013.11.004
22. Andersen O., Eugen-Olsen J., Kofoed K., Iversen J., Haugaard S. B., Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. Journal of Medical Virology 2008 80 2 209 216 2-s2.0-37549009178 10.1002/jmv.21114
23. Stephens R. W., Pedersen A. N., Nielsen H. J., Hamers M. J. A. G., Høyer-Hansen G., Rønne E., Dybkjær E., Danø K., Brünner N., ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clinical Chemistry 1997 43 10 1868 1876 2-s2.0-0030809697 (Pubitemid 27452275)
24. Huttunen R., Syrjänen J., Vuento R., Hurme M., Huhtala H., Laine J., Pessi T., Aittoniemi J., Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. Journal of Internal Medicine 2011 270 1 32 40 2-s2.0-79959331335 10.1111/j.1365-2796.2011.02363.x
25. Wiersinga W. J., Kager L. M., Hovius J. W. R., van der Windt G. J. W., de Vos A. F., Meijers J. C. M., Roelofs J. J., Dondorp A., Levi M., Day N. P., Peacock S. J., van der Poll T., Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. The Journal of Immunology 2010 184 6 3079 3086 2-s2.0-77951918695 10.4049/jimmunol.0901008
26. Rijneveld A. W., Levi M., Florquin S., Speelman P., Carmeliet P., Van der Poll T., Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. The Journal of Immunology 2002 168 7 3507 3511 2-s2.0-0036533484 (Pubitemid 34250418)
27. Wei C., El Hindi S., Li J., Fornoni A., Goes N., Sageshima J., Maiguel D., Karumanchi S. A., Yap H.-K., Saleem M., Zhang Q., Nikolic B., Chaudhuri A., Daftarian P., Salido E., Torres A., Salifu M., Sarwal M. M., Schaefer F., Morath C., Schwenger V., Zeier M., Gupta V., Roth D., Rastaldi M. P., Burke G., Ruiz P., Reiser J., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature Medicine 2011 17 8 952 960 2-s2.0-79961132981 10.1038/nm.2411